MaaT Pharma SA (EPA: MAAT)
France
· Delayed Price · Currency is EUR 8.30
+0.14 (1.72%)
Nov 19, 2024, 5:35 PM CET
MaaT Pharma Revenue
MaaT Pharma had revenue of 1.72M EUR in the half year ending June 30, 2024, with 248.38% growth. This brings the company's revenue in the last twelve months to 2.57M, up 11.11% year-over-year. In the year 2023, MaaT Pharma had annual revenue of 2.23M with 55.80% growth.
Revenue (ttm)
2.57M
Revenue Growth
+11.11%
P/S Ratio
38.13
Revenue / Employee
47.61K
Employees
60
Market Cap
114.69M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Ipsen S.A. | 3.44B |
| Eurofins Scientific SE | 6.72B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |